Corvus Pharmaceuticals, Inc. (CRVS) vs MoonLake Immunotherapeutics (MLTX)
Corvus Pharmaceuticals, Inc. and MoonLake Immunotherapeutics are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and MoonLake Immunotherapeutics are of similar size ($1.0B and $992.6M). Across the 10 metrics below, Corvus Pharmaceuticals, Inc. leads on 8 and MoonLake Immunotherapeutics on 2.
Valuation
Profitability
| Metric | CRVS | MLTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (18.98%) | (67.08%) | (57.72%) |
| Return on assets | (17.64%) | (51.00%) | (49.22%) |
| Return on invested capital | (352.49%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack